Antiinflammatory activity of 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates on carrageenan model of inflammation

Journal Title: Фармацевтичний журнал - Year 2019, Vol 4, Issue 4

Abstract

In the last decade, high cariesprophylactic efficacy of ammonium hexafluorosilicates, including salts with substituted biologically active ammonium cations, has been demonstrated. Among the promising anti-caries agents are recently synthesized 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates, for whose cations anti-inflammatory activity is expected. The aim of the work is to assess the presence of anti-inflammatory activity in the series of 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates in the experiment. 2-, 3-, 4-Carboxymethylpyridinium hexafluorosilicates (I–III, respectively) were synthesized according to the previously proposed technique, carrageenan is a commercial preparation, reference drug is a indomethacin. Experiments on the anti-inflammatory activity of hexafluorosilicates were performed on 77 white Wistar male rats weighing 174–190 g using the carrageenan model of inflammation. The inflammatory reaction was reproduced by subplantary administration of 0.1 ml of a 0.2% solution of carrageenan, the studied compounds were administered orally in doses 1/10, 1/20, 1/50 from LD50 for the compound III. It was established that after administration of carrageenan, animals of the control group showed marked paw edema, which gradually increased and was maximal after 24 hours of observation. According to the data obtained, the indices for compounds I-III practically do not differ from those of the control group. This indicates that, despite the results of the PASS forecast and the presence of acetic acid residue, an anti-inflammatory pharmacofor, in compounds I-III, the compounds under study do not have an anti-inflammatory effect in the carrageenan model. 2-, 3-, 4-Carboxymethylpyridinium hexafluorosilicates do not show the expected anti-inflammatory activity in the carrageenan model of inflammation.

Authors and Affiliations

B. V. Pristupa, I. O. Shyshkin, Ya. V. Rozhkovsky, V. O. Gelmboldt

Keywords

Related Articles

Economic aspects of pharmacotherapy of servicemen with injury and wound of the brain

The fighting in the area of the antiterrorist operation led to a large number of injuries among servicemen who are serving in the east of the country. Injuries and wound of the brain occupy about 35–40% among the total l...

Amino acids composition of herb of Lamiaceae family representatives

Researching of the amino acids contents in medicinal plant raw materials is an important task of pharmaceutical science and practice, because complexes of amino acids used for the corrections of hepatobiliary disorders,...

Spectral response аnd electronic structure оf synthetic coumarin derivatives. P a r t IV. Study оf the UV-spectra оf warfarin sodium clathrate

Warfarin is a vitamin K antagonist that was first developed by Wisconsion Alunini Research Foundation in 1947. The use of warfarin in the treatment fоr decrease blood clotting, promotes the emergence of a number of side...

The research of anti-inflammatory activity of 5-(5-bromofuran-2-yl)-4-ethyl-1,2,4-triazole-3-thion S-derivatives

The studing of anti-inflammatory activity of the novel compounds may give rise to the using of safer and more active drugs in the treatment of diseases which are shown NSAIDs. To further study the pharmacological prope...

Synthesis and establishment of physico-chemical constants 2-(5-( chinoline -2-il, 2-hydroxyquinoline-4-іл)-4-R1-1,2,4-triazole-3-ілтіо) acetate acids and their esther

The large interest in the plan of search biologically of active agents is caused by the heterocyclic system of 1,2,4-triazole, due to high biological activity, and by the low indexes of toxicness, that inherent it to the...

Download PDF file
  • EP ID EP635543
  • DOI 10.32352/0367-3057.4.19.09
  • Views 83
  • Downloads 0

How To Cite

B. V. Pristupa, I. O. Shyshkin, Ya. V. Rozhkovsky, V. O. Gelmboldt (2019). Antiinflammatory activity of 2-, 3-, 4-carboxymethylpyridinium hexafluorosilicates on carrageenan model of inflammation. Фармацевтичний журнал, 4(4), 82-87. https://www.europub.co.uk/articles/-A-635543